Cosmetic Softgel Quality Control RFQ Checklist: Capsule Quality Review Before Sampling

Direct Answer

A cosmetic softgel quality control RFQ checklist should require the ODM to define, before sampling, the commercial formula, capsule shell specification, fill-weight controls, mold ownership, packaging configuration, stability protocol, batch-release tests, and shipment conditions. The objective is not simply to receive an attractive sample. It is to confirm that the requested sample can be reproduced at production scale without changing raw-material origin, shell composition, processing parameters, or primary packaging.

For an international brand, the central question is whether the supplier operates a controlled manufacturing system or relies on technician judgment and post-production sorting. Request specifications, test methods, acceptance criteria, deviation procedures, and representative records—not assurances. FDA cosmetic GMP guidance identifies manufacturing controls, records, laboratory practices, and complaint handling as quality-system considerations, while ISO 22716 should be verified through a current certificate and audit scope. Review the FDA cosmetic GMP guidance. ([fda.gov](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-cosmetic-good-manufacturing-practices))

Key Takeaways for Private Label Buyers

• Freeze the target formula, shell material, color system, fragrance, fill weight, and packaging configuration before authorizing samples.
• Require numerical release criteria for leakage, weight variation, appearance, seal integrity, odor, oxidation indicators, and microbiological quality where applicable.
• Evaluate the capsule and its primary pack as one system; a stable bulk capsule may fail in a jar, blister, pouch, or high-humidity distribution lane.
• Confirm whether pilot and commercial production use the same equipment class, mold geometry, material suppliers, and process controls.
• Request stability evidence that reflects the intended market, warehouse exposure, transportation conditions, and consumer opening pattern.
• Treat undocumented substitutions, undefined rework, and subjective visual inspection as supply-chain risks requiring formal escalation.

Buyer Context

Serum capsules concentrate multiple failure modes into a small unit: the cosmetic formula must remain compatible with the shell, the shell must seal consistently, each capsule must deliver the intended fill mass, and the packaging must protect the finished product through storage and shipment. This makes supplier qualification materially different from sourcing a conventional cream or bottled facial oil.

The risk profile also changes by product route. Retinol capsules require disciplined oxidation and light-exposure controls. Facial oil capsules may place greater emphasis on fill viscosity, migration, odor stability, and shell softening. Eye serum capsules require precise unit dosing and low defect visibility because consumers inspect each capsule at close range. Cleansing oil and hair oil capsules may use different fill volumes, shell dimensions, dispensing behavior, and secondary packaging. Vegan shells introduce additional questions concerning polymer composition, plasticizer system, moisture sensitivity, and supplier continuity.

A quality incident in this format can escalate quickly from isolated leakage to contaminated secondary packaging, unreadable batch coding, retailer rejection, or a multi-market recall assessment. The RFQ therefore becomes a preliminary control plan, particularly when a brand is qualifying replacement capacity after a supplier quality event, a failed third-party audit, or an unexpected production interruption. Buyers should compare the proposed route against the supplier’s broader serum capsule products and determine whether the factory has working experience with the requested shell, fill, and pack combination.

Capsule Formula, Shell, Mold, and Packaging Factors

Fill Formula and Processability

Ask the ODM to disclose the approved ingredient list, key raw-material specifications, antioxidant strategy, colorant status, and restrictions on alternative sources. The sample formula should be the intended production formula—not a laboratory approximation that will later be adjusted for filling speed or shell compatibility. For colored shells or fills, verify permitted use against the FDA color additive permitted-use database for the target market. FDA notes that color additives must be approved for their stated use and may be subject to certification requirements. ([fda.gov](https://www.fda.gov/industry/color-additives))

Viscosity must remain within a validated operating window so that dosing is consistent without excessive heat or dilution. Request the fill-temperature range, mixing and deaeration controls, maximum bulk holding time, and controls for exposure to oxygen and light. Where the formula contains retinol or oxidation-sensitive oils, ask for assay or validated proxy testing, odor and color criteria, and the point at which nitrogen blanketing or reduced-headspace handling is used. Buyers evaluating private label retinol capsules should also verify that sample and production batches use the same active source and stabilization system.

Shell Material, Seal Integrity, and Aging

The RFQ should identify whether the shell is gelatin-based or vegan, together with the polymer, plasticizer, colorant, opacity, allergen status, animal origin statement where relevant, and supporting certificate documentation. Do not accept a generic statement such as plant-based shell without a composition declaration and change-control obligation.

Request defect definitions for leaking seams, pinholes, twins, bubbles, deformation, surface oil, sticking, brittleness, and color variation. The supplier should explain how seal integrity is tested during production and at batch release, how nonconforming capsules are segregated, and whether rejected material can be reworked. A buyer reviewing a cosmetic softgel capsule factory should also ask how shell moisture is controlled between encapsulation, drying, inspection, and packing.

Fill Weight and Mold Control

Nominal fill weight alone is insufficient. Request the target, internal control limits, finished-product acceptance limits, sampling frequency, balance calibration records, and response when a sample falls outside limits. Confirm whether the specification applies to net fill, total capsule weight, or both. If the dose is part of the consumer claim or usage instruction, QA and regulatory teams should approve the measurement basis before artwork is finalized.

For custom molds, establish who owns the tooling, where it is stored, whether cavities are uniquely identified, and how wear is monitored. Ask whether the sampling mold is identical to the production mold or merely similar in appearance. Custom shapes can affect drying uniformity, seam position, fill capacity, dispensing behavior, and pack-out efficiency. Review available cosmetic softgel products and skincare capsules OEM capabilities before approving a geometry that has not been demonstrated at commercial speed.

Packaging, Stability, and Distribution

The primary package must be included in compatibility work. Jars should be assessed for capsule-to-capsule adhesion, repeated consumer opening, headspace, liner performance, and moisture ingress. Blisters require confirmation of cavity dimensions, web and lidding compatibility, seal parameters, capsule removal force, and barrier performance. Pouches require seal validation and protection against crushing. Decorative coatings, inserts, desiccants, and internal trays must not transfer odor, color, or residue.

Stability should cover the final capsule-packaging system under relevant heat, humidity, light, and ambient conditions, with defined test intervals and acceptance criteria. Request both the protocol and available results, including any adverse trend that remained technically within specification. Independent providers such as Intertek’s regulatory testing and certification services illustrate the broader role of testing, inspection, assurance, and certification in product-risk management. ([intertek.com](https://www.intertek.com/cosmetics/))

Shipment qualification should address carton compression, vibration, temperature exposure, pallet pattern, and maximum storage conditions. Production-slot and documentation questions should be integrated with quality review rather than managed as a separate commercial workstream; this capsule production lead-time and documentation checklist provides a related procurement framework. ([serumcapsules.com](https://serumcapsules.com/capsule-lead-time-and-production-slot-planning-quality-documentation-and-production-questions-for-buyers/))

Decision Framework

ODM Manufacturing Considerations

Before requesting samples, ask the supplier to define what a sample represents. A useful sample should identify the proposed shell material, fill formula or formula family, nominal fill weight, capsule dimensions, mold status, packaging format, and intended storage conditions. Confirm whether the sample is made on production equipment or by a laboratory method. A hand-filled capsule may demonstrate appearance but may not predict sealing, weight consistency, or deformation during commercial production.

For fill formula customization, provide the target product type, such as retinol serum capsules, facial oil capsules, eye serum capsules, cleansing oil capsules, or hair oil capsules. Ask the manufacturer to review viscosity, volatile ingredients, fragrance load, pigment, botanical extracts, and oil compatibility before finalizing the formula. Request a documented change log when the formula is adjusted after the first sampling round. This prevents a buyer from approving one formula and receiving another version at scale.

Shell selection should be treated as a performance decision rather than a marketing label alone. Ask whether the capsule uses gelatin, a vegan shell, or another specified polymer system, and request the composition range, plasticizer type, colorant information, and storage limitations. For vegan capsules, confirm whether humidity sensitivity, sealing temperature, and shell flexibility differ from the reference sample. If a color or opacity is requested, verify that the supporting documentation is suitable for the destination market. The FDA color additive permitted-use database can help buyers check whether a colorant requires specific conditions or restrictions: FDA color additive permitted-use database.

Mold selection also deserves written confirmation. Ask whether the proposed mold is an existing standard, a modified tool, or a new custom mold; record capsule length, diameter, tip shape, and expected tolerance. Confirm who owns the mold, who pays for maintenance, and what happens if cavity wear changes appearance or fill capacity. A sample approval should include a retained reference set and measurable acceptance limits, not only a visual approval by email.

Packaging compatibility should be tested with the actual capsule and the intended primary pack. For jars, check capsule movement, oil migration, closure pressure, headspace, and contact with liners. For blister packs, review cavity depth, sealing temperature, foil or film compatibility, and whether the capsule rubs against the lidding material. Ask for packaging samples that have undergone realistic heat and humidity exposure. A retinol capsule or facial oil capsule may look acceptable immediately after filling but develop color, odor, or shell changes during storage.

Request a stability review that covers the formula, shell, and package as one system. The supplier should state the test duration, conditions, inspection points, and criteria for leakage, tackiness, color shift, odor change, fill separation, and package deformation. Also confirm the MOQ for the selected formula, shell, mold, and packaging combination. A lower initial quantity may be available only with a standard shell or existing mold, while a custom color, vegan shell, or printed package may require a larger production commitment.

Labeling documents should be identified before sampling is approved. Ask for the ingredient declaration format, batch or lot coding method, net content basis, storage statement, country-of-origin information, manufacturing address, and any available certificate or specification sheet. The supplier should explain which documents are supplied for each batch and which are project-level documents. For international distribution, consider independent regulatory testing or certification support such as Intertek’s regulatory testing and certification services.

Finally, define shipment conditions in the purchase specification. State the acceptable temperature range, humidity exposure, carton orientation, pallet requirements, shock protection, and data-logger expectations. Ask how the supplier handles a shipment delayed at customs or exposed to abnormal heat. This is especially important when a sudden capacity interruption, raw-material shortage, or quality investigation causes a shipment to remain in storage longer than planned.

Common Problems or Failure Cases

Shell brittleness: Capsules may crack at the tip or seam when moisture is too low, plasticizer balance is unsuitable, or the product is stored in a dry environment. Request compression, handling, and transport observations using the finished package rather than loose capsules only.

Sticking or shell deformation: Excess humidity, residual surface moisture, warm filling conditions, or tight packing can cause capsules to stick together or flatten. Check whether the supplier has defined spacing, cooling, and release conditions before packing.

Fill separation: Oil and active ingredients may separate during storage when the formula is not adequately structured. Ask for observations at different temperatures and for a clear description of acceptable appearance. A visually uniform sample at room temperature is not sufficient evidence for long-term performance.

Leakage: Leakage can result from incomplete sealing, excessive fill volume, incompatible fragrance components, rough handling, or package compression. Ask for leak inspection records, retained samples, and a response plan that distinguishes isolated handling damage from a process-wide defect.

Fragrance sensitivity: Fragrance materials and essential oils can interact with shell components, liners, or closure materials. Request a compatibility review using the final fragrance concentration and the final package. Do not approve a fragrance-free sample as evidence for a fragranced production formula.

Packaging deformation: Blister film, jar liners, and closures may warp under heat or pressure. Review filled packs after warehouse-style storage and transport simulation. If the brand has a global supply chain carbon or packaging requirement, include the requested material declaration and environmental records in the same approval file rather than treating them as a later procurement issue.

Supplier Checklist

• Record shell material, composition range, colorant documentation, dimensions, and storage limits.
• Confirm the formula version, viscosity range, fragrance level, oxidation-control approach, and fill-weight target.
• Identify whether the mold is standard, modified, or custom, and document ownership and maintenance responsibility.
• Request production-equipment samples, retained references, measurable acceptance criteria, and a sample revision history.
• Test the actual jar, blister, liner, foil, film, and closure with filled capsules.
• Review stability observations for heat, humidity, light exposure, leakage, odor, color, separation, and shell deformation.
• Confirm MOQ by formula, shell, mold, capsule color, and packaging configuration.
• Request labeling documents, ingredient declaration format, batch coding example, certificate availability, and origin records.
• Define carton orientation, temperature limits, humidity controls, palletization, and shipment data requirements.
• Ask how the supplier protects formula files through access controls, physical segregation, confidentiality procedures, and change authorization.
• Review labor, environmental, and third-party audit records when the brand requires responsible sourcing or when a prior supplier has failed an inspection.
• Obtain a written deviation, complaint, recall, and corrective-action procedure before issuing a production order.

FAQ

How can a supplier protect our proprietary serum formula?

Ask for a practical information-security description, not only a confidentiality promise. It should cover role-based system access, physical separation of formula records, sample labeling, visitor controls, document retention, subcontractor restrictions, and approval for formula changes. For highly sensitive retinol or facial oil formulas, ask who can download, print, or transfer the working documents.

How can we secure supply when key raw materials are scarce?

Request a written allocation policy, approved alternative-material list, safety-stock approach, and escalation process for strategic accounts. Confirm whether shell and fill materials have more than one qualified source and whether an origin change triggers renewed compatibility or stability review. A supplier should not promise priority supply without explaining the capacity rules and evidence behind that promise.

What should we do if the first sample leaks but the formula is commercially attractive?

Do not approve the formula based on appearance alone. Ask the supplier to isolate the failure mode, identify whether it involves shell composition, fill volume, sealing, fragrance, or packaging compression, and provide a corrected sample with comparison data. The revised sample should retain the same formula version unless a change is clearly disclosed.

Can one sample confirm that a vegan capsule shell will work for every package?

No. Shell behavior depends on humidity, fill chemistry, capsule dimensions, and packaging pressure. Test the vegan shell in the intended jar or blister, including storage at elevated heat and humidity. Request composition and handling guidance before making a market claim about the shell.

Which labeling documents should be requested before sampling?

Request a draft ingredient declaration, manufacturing and origin information, batch-code example, net-content basis, storage statement, shell material description, and available certificate or specification documents. The exact package wording still requires review for the destination market, but early documentation can reveal missing traceability or incompatible claims.

How should we assess worker treatment at a capsule factory?

Ask for recent social-compliance audit results, working-hour and wage records where permitted, grievance procedures, age-verification controls, and corrective-action reports. If the supplier refuses basic evidence or cannot explain how subcontracted packaging labor is monitored, treat that as a procurement risk. Responsible sourcing review should cover the facility producing and packing the capsules.

What shipment evidence should accompany the first commercial order?

Agree on packing photographs, carton and pallet details, lot identification, storage instructions, temperature or humidity records when needed, and a deviation report for abnormal transit conditions. These records help determine whether a later shell crack, leakage issue, or package deformation began during production, storage, or transportation.

References

FDA draft guidance for cosmetic good manufacturing practices supports review of documented manufacturing and quality practices relevant to cosmetic production.

FDA color additive permitted-use database supports verification of color additive status and permitted cosmetic use.

Intertek’s regulatory testing and certification services provides context for independent cosmetic testing, assessment, and certification support.